Elanco Animal Health Expands Kansas Facility to Meet Rising Global Demand
Elanco Animal Health is set to significantly enhance its production capabilities with the expansion of its Kansas manufacturing facility. This strategic investment is part of Elanco’s broader initiative to bolster its supply chain and accommodate the growing global demand for its animal health products. The Kansas facility, a key component of Elanco’s production network, will receive substantial infrastructure upgrades aimed at increasing production efficiency and capacity.
Elanco Welcomes Power Duo to Board
In a strategic move set to shape the future of animal health, Elanco Animal Health Incorporated (NYSE: ELAN) has announced the appointment of two dynamic leaders, Kathy Turner and Craig Wallace, to its esteemed Board of Directors. The expansion to 14 members signals a pivotal moment for the company as it gears up for unparalleled growth and innovation.
Farmers Hit Jackpot with Revolutionary Carbon Credit Scheme: Greenhouse Gases Turn Cash Cows
In an unprecedented move shaking up the agricultural sector, Athian (athian.ai) has unveiled the world's first voluntary livestock carbon insetting marketplace—a game-changer that promises to turn greenhouse gas emission reductions into lucrative opportunities for farmers. This groundbreaking initiative, backed by innovative feed management solutions from Elanco Animal Health (NYSE: ELAN), focuses on slashing enteric methane emissions and boosting feed efficiency, paving the way for dairy farmers nationwide to cash in on their sustainability efforts.
Merck Animal Health’s $1.3B Aqua Business Acquisition
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN) for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile. The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing conditions.